CVS Health Corp (NYSE:CVS) Shares Sold by Family Legacy Inc.

Share on StockTwits

Family Legacy Inc. lessened its holdings in shares of CVS Health Corp (NYSE:CVS) by 17.2% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,225 shares of the pharmacy operator’s stock after selling 1,082 shares during the quarter. Family Legacy Inc.’s holdings in CVS Health were worth $285,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Argyle Capital Management Inc. grew its position in shares of CVS Health by 1.2% in the 2nd quarter. Argyle Capital Management Inc. now owns 43,873 shares of the pharmacy operator’s stock worth $2,391,000 after acquiring an additional 500 shares in the last quarter. Mn Services Vermogensbeheer B.V. grew its position in shares of CVS Health by 198.9% in the 2nd quarter. Mn Services Vermogensbeheer B.V. now owns 663,783 shares of the pharmacy operator’s stock worth $36,170,000 after acquiring an additional 441,700 shares in the last quarter. RNC Capital Management LLC grew its position in shares of CVS Health by 2.9% in the 2nd quarter. RNC Capital Management LLC now owns 805,927 shares of the pharmacy operator’s stock worth $43,915,000 after acquiring an additional 22,642 shares in the last quarter. Brookstone Capital Management grew its position in shares of CVS Health by 15.8% in the 2nd quarter. Brookstone Capital Management now owns 6,053 shares of the pharmacy operator’s stock worth $330,000 after acquiring an additional 825 shares in the last quarter. Finally, Farmers & Merchants Investments Inc. grew its position in shares of CVS Health by 0.4% in the 2nd quarter. Farmers & Merchants Investments Inc. now owns 279,192 shares of the pharmacy operator’s stock worth $15,213,000 after acquiring an additional 1,014 shares in the last quarter. Hedge funds and other institutional investors own 77.33% of the company’s stock.

Several research analysts have recently commented on the company. SunTrust Banks decreased their target price on CVS Health from $85.00 to $65.00 in a research report on Wednesday, April 10th. Credit Suisse Group lowered CVS Health from an “outperform” rating to a “neutral” rating and decreased their target price for the stock from $73.00 to $61.00 in a research report on Monday, April 29th. Guggenheim assumed coverage on CVS Health in a research report on Thursday, April 18th. They issued a “buy” rating and a $75.00 target price for the company. ValuEngine lowered CVS Health from a “sell” rating to a “strong sell” rating in a research report on Tuesday, July 2nd. Finally, UBS Group decreased their target price on CVS Health from $74.00 to $67.00 and set a “sell” rating for the company in a research report on Thursday, May 2nd. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating, sixteen have given a buy rating and one has issued a strong buy rating to the company’s stock. CVS Health has a consensus rating of “Buy” and a consensus price target of $76.48.

Shares of NYSE CVS opened at $55.33 on Monday. The company has a market cap of $72.37 billion, a P/E ratio of 7.81, a price-to-earnings-growth ratio of 1.25 and a beta of 0.90. CVS Health Corp has a 12-month low of $51.72 and a 12-month high of $82.15. The company has a current ratio of 0.95, a quick ratio of 0.64 and a debt-to-equity ratio of 1.45. The business has a 50 day moving average of $55.36.

The business also recently declared a quarterly dividend, which was paid on Friday, August 2nd. Investors of record on Thursday, July 25th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 3.61%. The ex-dividend date of this dividend was Wednesday, July 24th. CVS Health’s dividend payout ratio (DPR) is 28.25%.

CVS Health Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Further Reading: Investing in Blue-Chip Stocks

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Dorothy C. Jenkins Sells 390 Shares of Westlake Chemical Co.  Stock
Dorothy C. Jenkins Sells 390 Shares of Westlake Chemical Co. Stock
Alex G. Morrison Buys 11,400 Shares of Energy Fuels Inc  Stock
Alex G. Morrison Buys 11,400 Shares of Energy Fuels Inc Stock
Sean P. Moriarty Sells 4,000 Shares of Leaf Group Ltd.  Stock
Sean P. Moriarty Sells 4,000 Shares of Leaf Group Ltd. Stock
Analysts Anticipate Apache Co.  Will Post Quarterly Sales of $1.55 Billion
Analysts Anticipate Apache Co. Will Post Quarterly Sales of $1.55 Billion
1-800-Flowers.Com  Releases FY 2020 Earnings Guidance
1-800-Flowers.Com Releases FY 2020 Earnings Guidance
Insider Selling: TrustCo Bank Corp NY  SVP Sells $18,672.00 in Stock
Insider Selling: TrustCo Bank Corp NY SVP Sells $18,672.00 in Stock


© 2006-2019 Ticker Report